Baring International Investment’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
$13.9M Sell
492,763
-121,274
-20% -$3.46M 0.88% 34
2014
Q1
$18.7M Sell
614,037
-273,906
-31% -$8.17M 1.1% 22
2013
Q4
$25.8M Sell
887,943
-249,634
-22% -$7.27M 1.4% 22
2013
Q3
$31M Sell
1,137,577
-448,531
-28% -$12.2M 1.38% 18
2013
Q2
$42.2M Buy
+1,586,108
New +$43.8M 1.82% 9

Other funds holding PFE

Baring International Investment's PFE Position: Q2 2014 in Review

Baring International Investment reduced its Pfizer (PFE) stake by 20% in Q2 2014, selling an estimated $3.46M and leaving 492,763 shares worth $13.9M. The position accounts for 0.88% of the portfolio, ranked #34.

Baring International Investment first reported a position in PFE in Q2 2013 and has held it in 5 quarters since. The position peaked at $42.2M in Q2 2013. 1,746 funds tracked by Wall St. Rank hold PFE as of Q2 2014.

  • Baring International Investment held 492,763 shares of Pfizer worth $13.9M as of Q2 2014.
  • Baring International Investment sold 121,274 Pfizer shares in Q2 2014, an estimated $3.46M.
  • Pfizer made up 0.88% of Baring International Investment's portfolio in Q2 2014, its #34 holding.
  • Baring International Investment first reported a position in Pfizer in Q2 2013 and has held it in 5 quarters since.
  • Baring International Investment's Pfizer position peaked at $42.2M in Q2 2013.
  • 1,746 funds tracked by Wall St. Rank held Pfizer as of Q2 2014.

Based on Baring International Investment's 13F filing for Q2 2014, filed 21 Jul 2014.